Literature DB >> 22367266

Characterization of effector memory CD8+ T cells in the synovial fluid of rheumatoid arthritis.

Bon-A Cho1, Ji Hyun Sim, Ji Ah Park, Hye Won Kim, Wan-Hee Yoo, Seung-Hyun Lee, Dong-Sup Lee, Jae Seung Kang, Young-Il Hwang, Wang Jae Lee, Insoo Kang, Eun Bong Lee, Hang-Rae Kim.   

Abstract

Little is known about the cellular characteristics of CD8(+) T cells in rheumatoid arthritis (RA). We addressed this by investigating whether the frequency of the CD8(+) T cell subsets and their phenotypic characteristics are altered in the peripheral blood and synovial fluid (SF) from patients with RA. In this study, CD8(+) T cells, mainly CD45RA(-) effector memory (EM) CD8(+) T cells, were increased significantly in the SF, but not in the peripheral blood from RA patients, compared with healthy controls. The synovial EM CD8(+) T cells were activated phenotypes with high levels of CD80, CD86, and PD-1, and had a proliferating signature in vivo upon Ki-67 staining, whereas the Fas-positive cells were prone to apoptosis. In addition, EM CD8(+) T cells in the SF were less cytotoxic, as they expressed less perforin and granzyme B. In particular, the proportions of synovial fluid mononuclear cells that were CCR4(+)CD8(+) T cells and IL-4-producing CD8(+) T cells (i.e., Tc2 cells) were significantly higher than those in peripheral blood mononuclear cells of patients with RA and healthy controls. In addition, the number of IL-10-producing CD8(+) suppressor T (Ts) cells increased significantly in the SF of RA patients. Especially, CD8(+) T cells were inversely correlated with disease activity. These findings strongly suggest that EM CD8(+) T cells in the SF are increased, likely because of inflammation, and they may be involved in modulating inflammation, thereby affecting the development and progression of RA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367266     DOI: 10.1007/s10875-012-9674-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  46 in total

1.  Role of CD8+ T cells in murine experimental allergic encephalomyelitis.

Authors:  H Jiang; S I Zhang; B Pernis
Journal:  Science       Date:  1992-05-22       Impact factor: 47.728

Review 2.  Fas (CD95)-related apoptosis and rheumatoid arthritis.

Authors:  S L Peng
Journal:  Rheumatology (Oxford)       Date:  2005-09-13       Impact factor: 7.580

3.  IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells.

Authors:  Nuno L Alves; Fernando A Arosa; René A W van Lier
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

Review 4.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

5.  Expression of functional B7 and CTLA4 on rheumatoid synovial T cells.

Authors:  J Verwilghen; R Lovis; M De Boer; P S Linsley; G K Haines; A E Koch; R M Pope
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

6.  The frequency of type 2 CD8+ T cells is increased in peripheral blood from patients with psoriasis vulgaris.

Authors:  Makoto Inaoki; Shinichi Sato; Fumiaki Shirasaki; Naofumi Mukaida; Kazuhiko Takehara
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

7.  CD27 defines phenotypically and functionally different human NK cell subsets.

Authors:  Mireille T M Vossen; Mourad Matmati; Kirsten M L Hertoghs; Paul A Baars; Mi-Ran Gent; Georges Leclercq; Jörg Hamann; Taco W Kuijpers; René A W van Lier
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

8.  Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice.

Authors:  N Itoh; A Imagawa; T Hanafusa; M Waguri; K Yamamoto; H Iwahashi; M Moriwaki; H Nakajima; J Miyagawa; M Namba; S Makino; S Nagata; N Kono; Y Matsuzawa
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

9.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

10.  Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells.

Authors:  Michel Gilliet; Yong-Jun Liu
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

View more
  33 in total

1.  DNA Methylation Regulates the Differential Expression of CX3CR1 on Human IL-7Rαlow and IL-7Rαhigh Effector Memory CD8+ T Cells with Distinct Migratory Capacities to the Fractalkine.

Authors:  Min Sun Shin; Sungyong You; Youna Kang; Naeun Lee; Seung-Ah Yoo; Kieyoung Park; Ki Soo Kang; Sang Hyun Kim; Subhasis Mohanty; Albert C Shaw; Ruth R Montgomery; Daehee Hwang; Insoo Kang
Journal:  J Immunol       Date:  2015-08-14       Impact factor: 5.422

2.  Germline Features Associated with Immune Infiltration in Solid Tumors.

Authors:  Sahar Shahamatdar; Meng Xiao He; Matthew A Reyna; Alexander Gusev; Saud H AlDubayan; Eliezer M Van Allen; Sohini Ramachandran
Journal:  Cell Rep       Date:  2020-03-03       Impact factor: 9.423

3.  PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation.

Authors:  Alessandra Petrelli; Gerdien Mijnheer; David P Hoytema van Konijnenburg; Maria M van der Wal; Barbara Giovannone; Enric Mocholi; Nadia Vazirpanah; Jasper C Broen; Dirkjan Hijnen; Bas Oldenburg; Paul J Coffer; Sebastian J Vastert; Berent J Prakken; Eric Spierings; Aridaman Pandit; Michal Mokry; Femke van Wijk
Journal:  J Clin Invest       Date:  2018-08-02       Impact factor: 14.808

Review 4.  Immune regulation of multiple sclerosis by CD8+ T cells.

Authors:  Sushmita Sinha; Farah R Itani; Nitin J Karandikar
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

Review 5.  CD8(+) T cells in human autoimmune arthritis: the unusual suspects.

Authors:  Alessandra Petrelli; Femke van Wijk
Journal:  Nat Rev Rheumatol       Date:  2016-06-03       Impact factor: 20.543

6.  OMIP-042: 21-color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood.

Authors:  Karl W Staser; William Eades; Jaebok Choi; Darja Karpova; John F DiPersio
Journal:  Cytometry A       Date:  2017-12-30       Impact factor: 4.355

7.  Role of cytolytic impairment of natural killer and natural killer T-cell populations in rheumatoid arthritis.

Authors:  Ashish Aggarwal; Aman Sharma; Archana Bhatnagar
Journal:  Clin Rheumatol       Date:  2014-05-07       Impact factor: 2.980

8.  Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer.

Authors:  Christopher S Nabel; Mariano Severgnini; Yin P Hung; Amy Cunningham-Bussel; Evisa Gjini; Katja Kleinsteuber; Lake J Seymour; Martha K Holland; Rachel Cunningham; Kristin D Felt; Marina Vivero; Scott J Rodig; Elena M Massarotti; Osama E Rahma; Lauren C Harshman
Journal:  Oncologist       Date:  2019-05-14

9.  ERAP1 functions override the intrinsic selection of specific antigens as immunodominant peptides, thereby altering the potency of antigen-specific cytolytic and effector memory T-cell responses.

Authors:  David P W Rastall; Yasser A Aldhamen; Sergey S Seregin; Sarah Godbehere; Andrea Amalfitano
Journal:  Int Immunol       Date:  2014-08-02       Impact factor: 4.823

Review 10.  T cells out of control--impaired immune regulation in the inflamed joint.

Authors:  Ellen J Wehrens; Berent J Prakken; Femke van Wijk
Journal:  Nat Rev Rheumatol       Date:  2013-01       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.